tazobactam has been researched along with dextrothyroxine in 2 studies
| Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (dextrothyroxine) | Trials (dextrothyroxine) | Recent Studies (post-2010) (dextrothyroxine) |
|---|---|---|---|---|---|
| 1,327 | 153 | 694 | 7,511 | 855 | 3,349 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barie, PS; Cayci, C; Eachempati, SR; Fusco, D; Goldstein, MJ; Huston, JM; Kapur, S; Mathew, M; Rodney, JR; Shou, J | 1 |
| Aranda-Aguirre, E; Guerrero-Wooley, R; Li, W; Palavecino, E; Wilkin, A | 1 |
2 other study(ies) available for tazobactam and dextrothyroxine
| Article | Year |
|---|---|
Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient.
Topics: Aged, 80 and over; Albendazole; Animals; Anti-Infective Agents; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Ivermectin; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Protein C; Recombinant Proteins; Respiratory Distress Syndrome; Shock, Septic; Strongyloides stercoralis; Strongyloidiasis; Superinfection; Tazobactam; Treatment Outcome | 2009 |
Case Report:
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents, Immunological; Antiparasitic Agents; Bacteremia; Fatal Outcome; Humans; Immunocompromised Host; Ivermectin; Klebsiella pneumoniae; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Penicillanic Acid; Piperacillin; Rituximab; Strongyloides stercoralis; Strongyloidiasis; Tazobactam | 2017 |